Literature DB >> 7240250

Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.

H Nawata, M T Chong, D Bronzert, M E Lippman.   

Abstract

An estrogen-independent variant (R3) was selected by cloning wild type MCF-7 cells in soft agar in the presence of tamoxifen. R3 has a slightly slower growth rate under optimal growth conditions. Estradiol and tamoxifen have minimal effects on growth rate and thymidine incorporation as compared to wild type MCF-7 cells. R3 contains both cytoplasmic receptor and a receptor derived from crude nuclear extract with slightly higher numbers of cytosol receptor than wild type MCF-7. The same dissociation constant (Kd) and the same molecular weight (estimated by Sephadex chromatography) and sucrose density behavior for both cytoplasmic and nuclear estrogen receptor are seen in R3 and MCF-7. Estrogen receptor complexes were activated by salt and nucleotide and translocated to the nucleus equivalently in R3 and MCF-7. Relative binding affinities and extent of competition by estradiol and tamoxifen for cytoplasmic estrogen receptor are the same for MCF-7 and R3. Induction of progesterone receptor and nuclear estrogen receptor processing following treatment with estradiol in R3 is minimal compared with MCF-7. DNA affinity (as assessed by DNA cellulose chromatography) of estrogen receptor complexes from R3 and MCF-7 is different. R3 appears to represent a cell with a defect expressed in receptor function apart from the initial hormone-binding step.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240250

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.

Authors:  R Hackenberg; J Hofmann; G Wolff; F Hölzel; K D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.

Authors:  R A Sorace; C S Bagley; A S Lichter; D N Danforth; M W Wesley; R C Young; M E Lippman
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 3.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  On the mechanism of estrogen receptor replenishment: recycling, resynthesis and/or processing.

Authors:  J A Kassis; J Gorski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

Authors:  Kelley Salem; Manoj Kumar; Kyle C Kloepping; Ciara J Michel; Yongjun Yan; Amy M Fowler
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

6.  Functional estrogen receptors in a human preosteoclastic cell line.

Authors:  G Fiorelli; F Gori; M Petilli; A Tanini; S Benvenuti; M Serio; P Bernabei; M L Brandi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Effect of estrogens on boar sperm capacitation in vitro.

Authors:  Lukas Ded; Pavla Dostalova; Andriy Dorosh; Katerina Dvorakova-Hortova; Jana Peknicova
Journal:  Reprod Biol Endocrinol       Date:  2010-07-13       Impact factor: 5.211

8.  The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.

Authors:  P T Jain; J T Pento; R A Magarian
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.

Authors:  D M Wolf; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Familial incomplete male pseudohermaphroditism associated with impaired nuclear androgen retention. Studies in cultured skin fibroblasts.

Authors:  C Eil
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.